The FDA has issued a warning to Savannah Chrisley regarding alleged false and misleading statements on her prescription weight loss website, GoodGirlRX. The federal agency's letter, obtained by TMZ, flagged problematic claims about compounded semaglutide and tirzepatide products, specifically the use of phrases like 'FDA-approved meds' and 'clinically proven GLP-1 results.'

According to the FDA, these compounded drug products are not FDA-approved, and the claims implied they had been evaluated for safety and effectiveness when they had not. The agency gave Chrisley 15 business days to make corrections or face potential legal action. The warning letter represents a significant regulatory challenge for celebrity-endorsed wellness ventures.

Chrisley has since updated her website, changing 'clinically proven' to 'clinically studied' and adding disclaimers that the GLP-1 drugs are not FDA-approved. She told TMZ the issue was about website wording, not patient safety, noting there were no fines or disciplinary action. The incident highlights the scrutiny faced by celebrity health and wellness businesses in the expanding weight loss market.